Literature DB >> 23732512

Effect modification by transferrin C2 polymorphism on lead exposure, hemoglobin levels, and IQ.

Ananya Roy1, Adrienne S Ettinger, Howard Hu, David Bellinger, Joel Schwartz, Rama Modali, Robert O Wright, Kavitha Palaniappan, Kalpana Balakrishnan.   

Abstract

BACKGROUND: Iron deficiency and lead exposure remain significant public health issues in many parts of the world and are both independently associated with neurocognitive deficits. Polymorphisms in iron transport pathways have been shown to modify the absorption and toxicity of lead.
OBJECTIVE: We hypothesized that the transferrin (TF) C2 polymorphism modifies the effects of lead and hemoglobin on intelligence.
METHODS: Children aged 3-7 years (N=708) were enrolled from 12 primary schools in Chennai, India. The Binet-Kamath Scale of Intelligence were administered to ascertain intelligence quotient (IQ). Venous blood was analyzed for lead and hemoglobin levels. Genotyping for the TF C2 polymorphism (rs1049296) was carried out using a MassARRAY iPLEXTM platform. Stratified analyses and interaction models, using generalized estimating equations, were examined to explore interactions between lead, hemoglobin, and TF C2 categories.
RESULTS: A one-unit increase in log blood lead and 1g/dl higher hemoglobin was associated with -77 (95% CI: -136, -18) and 17 (95% CI 14, 21) IQ points, respectively, among children carrying the C2 variant. In comparison, among children who had the homozygous wildtype allele, the same increment of lead and hemoglobin were associated with -21(95% CI: -65, 24) and 28 (95% CI: 15, 40) IQ points, respectively. There was a significant interaction between lead (p=0.04) and hemoglobin (p=0.07) with the C2 variant.
CONCLUSION: Children who carry the TF C2 variant may be more susceptible to the neurotoxic effects of lead exposure and less protected by higher levels of hemoglobin.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genotype; Hemoglobin; Intelligence quotient (IQ); Iron; Lead; Transferrin

Mesh:

Substances:

Year:  2013        PMID: 23732512      PMCID: PMC3770761          DOI: 10.1016/j.neuro.2013.05.005

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  48 in total

1.  Association between iron deficiency and blood lead level in a longitudinal analysis of children followed in an urban primary care clinic.

Authors:  Robert O Wright; Shirng-Wern Tsaih; Joel Schwartz; Rosalind J Wright; Howard Hu
Journal:  J Pediatr       Date:  2003-01       Impact factor: 4.406

2.  Effects of transferrin genetic phenotypes on total iron-binding capacity.

Authors:  C T Wong; N Saha
Journal:  Acta Haematol       Date:  1986       Impact factor: 2.195

Review 3.  HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology.

Authors:  E H Hanson; G Imperatore; W Burke
Journal:  Am J Epidemiol       Date:  2001-08-01       Impact factor: 4.897

4.  Transferrin C2 as an enhancer of cyto- and genotoxic damage.

Authors:  L Beckman; G Beckman
Journal:  Prog Clin Biol Res       Date:  1986

Review 5.  Interactions between iron deficiency and lead poisoning: epidemiology and pathogenesis.

Authors:  Wilson T Kwong; Phyllis Friello; Richard D Semba
Journal:  Sci Total Environ       Date:  2004-09-01       Impact factor: 7.963

Review 6.  Divalent metal transporter 1 in lead and cadmium transport.

Authors:  Joseph P Bressler; Luisa Olivi; Jae Hoon Cheong; Yongbae Kim; Desmond Bannona
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

7.  Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models.

Authors:  E Ortiz; J M Pasquini; K Thompson; B Felt; G Butkus; J Beard; J R Connor
Journal:  J Neurosci Res       Date:  2004-09-01       Impact factor: 4.164

Review 8.  Brain iron homeostasis.

Authors:  Torben Moos
Journal:  Dan Med Bull       Date:  2002-11

9.  Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.

Authors:  K J H Robson; D J Lehmann; V L C Wimhurst; K J Livesey; M Combrinck; A T Merryweather-Clarke; D R Warden; A D Smith
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

10.  5- and 6-glycosylation of transferrin in patients with Alzheimer's disease.

Authors:  Susan J van Rensburg; Peter Berman; Felix Potocnik; Pam MacGregor; Dinie Hon; Nico de Villiers
Journal:  Metab Brain Dis       Date:  2004-06       Impact factor: 3.584

View more
  3 in total

Review 1.  Exposure to Mixtures of Metals and Neurodevelopmental Outcomes: A Multidisciplinary Review Using an Adverse Outcome Pathway Framework.

Authors:  Katherine von Stackelberg; Elizabeth Guzy; Tian Chu; Birgit Claus Henn
Journal:  Risk Anal       Date:  2015-06-10       Impact factor: 4.000

Review 2.  Environmental Metal Exposure, Neurodevelopment, and the Role of Iron Status: a Review.

Authors:  Samantha Schildroth; Katarzyna Kordas; Julia Anglen Bauer; Robert O Wright; Birgit Claus Henn
Journal:  Curr Environ Health Rep       Date:  2022-08-23

3.  Maternal iron metabolism gene variants modify umbilical cord blood lead levels by gene-environment interaction: a birth cohort study.

Authors:  Mateusz P Karwowski; Allan C Just; David C Bellinger; Rebecca Jim; Earl L Hatley; Adrienne S Ettinger; Howard Hu; Robert O Wright
Journal:  Environ Health       Date:  2014-10-06       Impact factor: 5.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.